公募基金费率改革正在迎来从降费让利到机制重构的纵深推进。 此外，第二批浮动费率基金也发行提速，其中易方达价值回报、中欧核心智选两只新型浮动费率基金已 经提前结束募集，募集金额均超20亿元。 相比首批产品，第二批新型浮动费率模式已再次有所创新。一是投资策略更加多元，除了全市场选股产 品外，第二批还有聚焦行业或者主题的产品，比如建信医疗创新、华泰柏瑞制造业主题混合等产品；二 是费率降档阈值设定更加严格。比如，相较新型浮动费率产品普遍"跑赢6个百分点、跑输3个百分点"的 年化超额升降档阈值，华泰柏瑞制造业主题混合基金将降档阈值调整为"跑输2个百分点"，对基金管理 人提出了更高要求。 华泰柏瑞基金表示，新型浮动费率模式的意义远不止于费率本身的变化，同时，它还通过费率机制设 计，强化管理人与投资者利益的深度绑定，建立了更公平的利益共享、风险共担机制。在浮动费率模式 下，管理费收入直接与基金创造的超额收益挂钩，这直接推动基金管理人将核心资源投入到提升主动管 理能力、创造超额收益上，努力帮投资者多赚钱。 自2023年7月证监会发布实施《公募基金行业费率改革工作方案》以来，公募基金费率改革正在按照"管 理费用—交易费用—销售 ...

Core Insights - A total of 19 public funds have launched their initial fundraising on August 4, including three products from the second batch of new floating-rate funds: E Fund Value Return Mixed, China Europe Core Select Mixed, and Jianxin Medical Innovation Stock [1] Fund Details - China Europe Core Select Mixed is set to end its fundraising on August 15, E Fund Value Return Mixed on August 20, and Jianxin Medical Innovation Stock on August 22 [1] - Jianxin Medical Innovation has a fundraising cap of 3 billion yuan [1] Fund Management - E Fund Value Return is managed by Tang Bolun, Jianxin Medical Innovation by Ma Muqing, and China Europe Core Select by Zhang Cong and Song Ting [1] Fund Approval and Themes - The second batch of new floating-rate funds was approved on July 24, covering various industry themes such as pharmaceuticals, manufacturing, and high-end equipment, along with initiator funds [1] - Among the new products, there are 2 stock-type funds and 10 equity-mixed funds, including: Invesco Great Wall High-end Equipment Stock, Jianxin Medical Innovation Stock, Bank of China Quality Emerging Mixed, Ping An Research-Driven Mixed, Southern Ruijing Mixed, Oriental Red Medical Innovation Mixed, E Fund Value Return Mixed, Huatai-PB Manufacturing Theme Mixed, Guotai Quality Core Mixed, China Europe Core Select Mixed, and Morgan Huikai Growth Mixed [1]

Core Viewpoint - The approval of a second batch of 12 new model floating management fee rate funds marks an expansion in the market, with a focus on industry-specific themes alongside general market selection products [1][2]. Group 1: Fund Approval and Structure - The newly approved funds include thematic products in high-end equipment, pharmaceuticals, and manufacturing, expanding beyond the first batch which focused solely on general market selection [1]. - Fund managers such as Guotai Fund, Huatai-PB Fund, Morgan Asset Management, and others are participating for the first time, while some like China Europe Fund and Oriental Red Asset Management are reapplying after the first batch [1]. - The floating management fee structure links fees to fund performance against a benchmark, with rates set at 1.2% for the baseline, 1.5% for an upgrade, and 0.6% for a downgrade, aligning the interests of fund managers and investors [1]. Group 2: Differentiation and Strategy - Huatai-PB Fund and Oriental Red Asset Management have implemented differentiated thresholds for their products, raising the downgrade threshold to 2 percentage points below the benchmark, enhancing performance accountability [2]. - The new model aims for a "one client, one share" fee structure, allowing for personalized fee arrangements, which is a shift from previous models that linked fees to overall fund performance [2]. - The introduction of thematic funds indicates a strategic shift from broad market selection to more specialized investment strategies, catering to diverse investor needs [2]. Group 3: Investment Opportunities - The Huatai-PB Manufacturing Theme Mixed Fund exemplifies the potential in China's manufacturing sector, which is undergoing a transformation towards high-end and intelligent manufacturing, presenting numerous investment opportunities [3]. - Investors are advised to consider the investment capabilities and philosophies of fund companies and managers, as well as specific details in fund contracts regarding fee structures and performance benchmarks, to align with their risk tolerance and investment goals [3].

Core Viewpoint - The second batch of 11 floating fee rate new funds has been submitted for approval, expanding from the first batch of 26 funds, and includes both broad market selection products and industry-specific thematic products, particularly in sectors like pharmaceuticals, high-end equipment, and manufacturing [1][2]. Group 1: Fund Characteristics - The new floating fee rate funds are designed to meet investor demand for quality technology investment tools and leverage the research team's expertise in the technology growth sector [1][6]. - The second batch includes a diverse range of products, moving from broad market strategies to more specialized thematic strategies, indicating a richer variety of offerings to cater to different investor preferences [2][3]. - The management fee structure remains at three tiers: 1.2% (benchmark), 1.5% (upward adjustment), and 0.6% (downward adjustment), with specific conditions for fee application based on fund performance relative to benchmarks [2][3]. Group 2: Industry Focus - High-end equipment and pharmaceuticals are highlighted as key sectors for the new thematic funds, with high-end equipment being a core support of the modern industrial system and a significant part of technology investment [6]. - The pharmaceutical sector, particularly the innovative drug segment, is experiencing rapid revenue growth, with companies poised to enter international markets, indicating substantial future opportunities [6]. - The focus on biotechnology companies with global market potential and traditional pharmaceutical companies undergoing successful transformations is emphasized as a strategic investment direction [6].

Core Viewpoint - The second batch of new floating-rate funds has been officially submitted for registration, following the first batch's successful fundraising, indicating a significant reform in the public fund industry aimed at enhancing investor returns and aligning fund management fees with actual long-term performance [1][2][4]. Group 1: Fund Registration and Types - On July 4, the China Securities Regulatory Commission (CSRC) announced that 11 public fund companies, including E Fund and Huatai-PB, have submitted applications for the second batch of floating-rate funds [1][2]. - Unlike the first batch, which consisted entirely of all-market funds, the second batch includes industry-themed products such as Huatai-PB's manufacturing theme mixed fund and Invesco Great Wall's high-end equipment stock fund [2]. Group 2: Fund Performance and Fundraising - As of July 4, 24 out of 26 funds from the first batch have completed fundraising, totaling approximately 22.68 billion yuan, with an average fundraising size of about 944.5 million yuan per fund [4]. - Notably, three funds exceeded 1.5 billion yuan in fundraising, while 14 funds raised between 500 million yuan and 1 billion yuan, indicating a strong market response [4]. Group 3: Fee Structure and Investor Alignment - The floating-rate fund model aims to enhance the alignment of interests between fund managers and investors by linking management fees to the actual long-term returns achieved by investors [3][7]. - The new fee structure is designed to encourage a long-term investment perspective among investors, moving away from a focus on short-term gains [3][7]. Group 4: Future Trends and Industry Impact - The CSRC plans to promote the floating management fee model for newly established actively managed equity funds, aiming for at least 60% of such funds to adopt this model within a year [7]. - This shift is expected to transform the public fund industry from a focus on scale to a focus on investor returns, marking a significant trend in supply-side reform [7][8].